References
- Gohari M, Dastgheib SA, Noorishadkam M, Lookzadeh MH, Mirjalili SR, Akbarian-Bafghi MJ, Morovati-Sharifabad M, Neamatzadeh H. Association of eNOS and ACE polymorphisms with retinopathy of prematurity: a systematic review and meta-analysis. Fetal Pediatr Pathol. 2019;1–12. doi:https://doi.org/10.1080/15513815.2019.1652378. [Epub ahead of print].
- Shastry BS. Genetic susceptibility to advanced retinopathy of prematurity (ROP). J Biomed Sci. 2010;17:69. doi:https://doi.org/10.1186/1423-0127-17-69.
- Lang DM, Blackledge J, Arnold RW. Is Pacific race a retinopathy of prematurity risk factor? Arch Pediatr Adolesc Med. 2005;159:771–3. doi:https://doi.org/10.1001/archpedi.159.8.771.
- Port AD, Chan RVP, Ostmo S, Choi D, Chiang MF. Risk factors for retinopathy of prematurity: insights from outlier infants. Graefes Arch Clin Exp Ophthalmol. 2014;252:1669–77. doi:https://doi.org/10.1007/s00417-014-2716-1.
- Wolforth LM, Loo SW, Sood SL. Retinopathy of prematurity and ethnicity in Hawai’i: a retrospective study (1996 - 2006) of medical records from Kapi’olani Medical Center for Women and Children. Hawaii J Med Public Health. 2016;75:68–72.
- Zhang S, Zhai G, Shi W, Wang Y, Zhu L, Dai Y, Chen C. Pigment epithelium-derived factor inhibits oxygen-induced retinal neovascularization in a murine model. Fetal Pediatr Pathol. 2016;35:173–85. doi:https://doi.org/10.3109/15513815.2016.1147626.
- Al Amro SA, Al Aql F, Al Hajar S, Al Dhibi H, Al Nemri A, Mousa A, Ahmad J. Practical guidelines for screening and treatment of retinopathy of prematurity in Saudi Arabia. Saudi J Ophthalmol. 2018;32:222–6. doi:https://doi.org/10.1016/j.sjopt.2018.07.007.
- Gudlavalleti VS, Shukla R, Batchu T, Malladi BVS, Gilbert C. Public health system integration of avoidable blindness screening and management, India. Bull World Health Organ. 2018;96:705–15. doi:https://doi.org/10.2471/BLT.18.212167.
- Larsson E, Holmström G. Screening for retinopathy of prematurity: evaluation and modification of guidelines. Br J Ophthalmol. 2002;86:1399–402. doi:https://doi.org/10.1136/bjo.86.12.1399.
- Jefferies AL, Canadian Paediatric Society, Fetus and Newborn Committee. Retinopathy of prematurity: an update on screening and management. Paediatr Child Health. 2016;21:101–8. doi:https://doi.org/10.1093/pch/21.2.101.
- Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989;161:851–8. doi:https://doi.org/10.1016/0006-291X(89)92678-8.
- Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983–5. doi:https://doi.org/10.1126/science.6823562.
- Shibuya M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer. 2011;2:1097–105. doi:https://doi.org/10.1177/1947601911423031.
- Abhinand CS, Raju R, Soumya SJ, Arya PS, Sudhakaran PR. VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis. J Cell Commun Signal. 2016;10:347–54. doi:https://doi.org/10.1007/s12079-016-0352-8.
- Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME. Vascular endothelial growth factor in eye disease. Prog Retinal Eye Res. 2008;27:331–71. doi:https://doi.org/10.1016/j.preteyeres.2008.05.001.
- Takagi H, King GL, Ferrara N, Aiello LP. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci. 1996;37:1311–21.
- Stavri GT, Hong Y, Zachary IC, Breier G, Baskerville PA, Ylä-Herttuala S, Risau W, Martin JF, Erusalimsky JD. Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Lett. 1995;358:311–5. doi:https://doi.org/10.1016/0014-5793(94)01458-D.
- Lei X-J, Zhao Y-X, Qiao T. Influence of polymorphisms in VEGF, ACE, TNF and GST genes on the susceptibility to retinopathy of prematurity among Chinese infants. Int J Ophthalmol. 2018;11:1451–7. doi:https://doi.org/10.18240/ijo.2018.09.04.
- Yang XM, Zhao YX, Wang ZH, Liu L. Effect of anti-VEGF treatment on retinopathy of prematurity in Zone II Stage 3+. Int J Ophthalmol. 2018;11:641–4. doi:https://doi.org/10.18240/ijo.2018.04.17.
- Eldweik L, Mantagos IS. Role of VEGF inhibition in the treatment of retinopathy of prematurity. Semin Ophthalmol. 2016;31:163–8. doi:https://doi.org/10.3109/08820538.2015.1114847.
- Arcondéguy T, Lacazette E, Millevoi S, Prats H, Touriol C. VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level. Nucleic Acids Res. 2013;41:7997–8010. doi:https://doi.org/10.1093/nar/gkt539.
- Pozarowska D, Pozarowski P. The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy. Cent Eur J Immunol. 2016;41:311–6. doi:https://doi.org/10.5114/ceji.2016.63132.
- Malik MA, Shukla S, Azad SV, Kaur J. Vascular endothelial growth factor (VEGF-634G/C) polymorphism and retinopathy of prematurity: a meta-analysis. Saudi J Ophthalmol. 2014;28:299–303. doi:https://doi.org/10.1016/j.sjopt.2014.07.001.
- Kwinta P, Bik-Multanowski M, Mitkowska Z, Tomasik T, Pietrzyk JJ. The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2008;246:1467–75. doi:https://doi.org/10.1007/s00417-008-0865-9.
- Poggi C, Giusti B, Gozzini E, Sereni A, Romagnuolo I, Kura A, Pasquini E, Abbate R, Dani C. Genetic contributions to the development of complications in preterm newborns. PLoS One. 2015;10:e0131741. doi:https://doi.org/10.1371/journal.pone.0131741.
- Dunai G, Vásárhelyi B, Szabó M, Hajdú J, Mészáros G, Tulassay T, Treszl A. Published genetic variants in retinopathy of prematurity: random forest analysis suggests a negligible contribution to risk and severity. Curr Eye Res. 2008;33:501–5. doi:https://doi.org/10.1080/02713680802018427.
- Sobhan MR, Mahdinezhad-Yazdi M, Moghimi M, Aghili K, Jafari M, Zare-Shehneh M, Neamatzadeh H. Plasminogen activator inhibitor-1 4G/5G polymorphism contributes to osteonecrosis of the femoral head susceptibility: evidence from a systematic review and meta-analysis. Arch Bone Jt Surg. 2018;6:468–77. doi:https://doi.org/10.22038/ABJS.2018.31668.1828.
- Cooke RWI, Drury JA, Mountford R, Clark D. Genetic polymorphisms and retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2004;45:1712–5. doi:https://doi.org/10.1167/iovs.03-1303.
- Vannay Á, Dunai G, Bányász I, Szabó M, Vámos R, Treszl A, Hajdú J, Tulassay T, Vásárhelyi B. Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Pediatr Res. 2005;57:396–8. doi:https://doi.org/10.1203/01.PDR.0000153867.80238.E0.
- Shastry BS, Qu X. Lack of association of the VEGF gene promoter (-634 G > C and -460 C > T) polymorphism and the risk of advanced retinopathy of prematurity. Graefe’s Arch Clin Exp Ophthalmol. 2007;245:741–3. doi:https://doi.org/10.1007/s00417-006-0480-6.
- Kaya M, Çokakli M, Berk AT, Yaman A, Yesilirmak D, Kumral A, Atabey N. Associations of VEGF/VEGF-receptor and HGF/c-Met promoter polymorphisms with progression/regression of retinopathy of prematurity. Curr Eye Res. 2013;38:137–42. doi:https://doi.org/10.3109/02713683.2012.731550.
- Ali AA, Hussien NF, Samy RM, Husseiny KA. Polymorphisms of vascular endothelial growth factor and retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 2015;52:245–53. doi:https://doi.org/10.3928/01913913-20150506-02.
- Huang L, Wu Z, Zhang G. Association between genetic polymorphisms of vascular endothelial growth factor and the prognosis of retinopathy of prematurity. Zhonghua Yandibing Xue Zazhi. 2008;24:45–8. doi:https://doi.org/10.3928/01913913-20150506-02.
- Kalmeh ZA, Azarpira N, Mosallaei M, Hosseini H, Malekpour Z. Genetic polymorphisms of vascular endothelial growth factor and risk for retinopathy of prematurity in South of Iran. Mol Biol Rep. 2013;40:4613–8. doi:https://doi.org/10.1007/s11033-013-2554-y.
- Yagi M, Yamamori M, Morioka I, Yokoyama N, Honda, Negi A, Nakamura T, Okamura N, Okumura K, Sakaeda T, et al. VEGF 936C > T is predictive of threshold retinopathy of prematurity in Japanese infants with a 30-week gestational age or less. Res Rep Neonatol. 2011;2011:5–11. doi:https://doi.org/10.2147/rrn.s17243.
- Gismondi D, Ndoja L, Qu X, Shastry BS. Lack of association of VEGF gene 3’- UTR polymorphisms (C702T, C936T and G1612A) and the risk of developing advanced retinopathy of prematurity (ROP). Graefes Arch Clin Exp Ophthalmol. 2013;251:413–5. doi:https://doi.org/10.1007/s00417-011-1913-4.
- Forat-Yazdi M, Jafari M, Kargar S, Abolbaghaei SM, Nasiri R, Farahnak S, Foroughi E, Neamatzadeh H. Association between SULT1A1 Arg213His (rs9282861) polymorphism and risk of breast cancer: a systematic review and meta-analysis. J Res Health Sci. 2017;17:e00396.
- Berardi R, Torniai M, Partelli S, Rubini C, Pagliaretta S, Savini A, Polenta V, Santoni M, Giampieri R, Onorati S, et al. Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms. PLoS One. 2018;15:e0197035. doi:https://doi.org/10.1371/journal.pone.0197035.
- Shukla S, Malik MA, Chandra P, Kaur J. Association between VEGF polymorphisms (-460 T/C and +936 C/T) and retinopathy of prematurity risk: a meta-analysis. Saudi J Ophthalmol. 2016;30:157–62. doi:https://doi.org/10.1016/j.sjopt06.003.
- Madan A, Penn JS. Animal models of oxygen-induced retinopathy. Front Biosci. 2003;8:d1030–43. doi:https://doi.org/10.2741/1056.
- Liu P, Wu D, Zhou W, Li Y, Lian C, Yang Y, Feng Z. Association of VEGF gene polymorphisms with advanced retinopathy of prematurity: a meta-analysis. Mol Biol Rep. 2012;39:10731–7. doi:https://doi.org/10.1007/s11033-012-1964-6.
- Zhai J, Jiang Q-H, Liu C-X, Tian Z-R, Sun Y-P. Meta analysis on the relationship between gene polymorphisms of vascular endothelial growth factor and retinal prognosis risk of prematurity. Int J Ophthalmol. 2012;5:397–400. doi:https://doi.org/10.3980/j.issn.2222-3959.2012.03.29.
- Yazdi MM, Jamalaldini MH, Sobhan MR, Jafari M, Mazaheri M, Zare-Shehneh M, Neamatzadeh H. Association of ESRα gene Pvu II T > C, XbaI A > G and BtgI G > A polymorphisms with knee osteoarthritis susceptibility: a systematic review and meta-analysis based on 22 case-control studies. Arch Bone Jt Surg. 2017;5:351–62.
- Namazi A, Forat-Yazdi M, Jafari M, Farahnak S, Nasiri R, Foroughi E, Abolbaghaei SM, Neamatzadeh H. Association of interleukin-10 -1082 a/G (Rs1800896) polymorphism with susceptibility to gastric cancer: meta-analysis of 6,101 cases and 8,557 controls. Arq Gastroenterol. 2018;55:33–40. doi:https://doi.org/10.1590/s0004-2803.201800000-18.
- Moghimi M, Kargar S, Jafari MA, Ahrar H, Jarahzadeh MH, Neamatzadeh H, Sadeghizadeh-Yazdi J. Angiotensin converting enzyme insertion/deletion polymorphism is associated with breast cancer risk: a meta-analysis. Asian Pac J Cancer Prev. 2018;19:3225–31. doi:https://doi.org/10.31557/APJCP.2018.19.11.3225.
- Jafari-Nedooshan J, Moghimi M, Zare M, Heiranizadeh N, Morovati-Sharifabad M, Akbarian-Bafghi MJ, Jarahzadeh MH, Neamatzadeh H. Association of promoter region polymorphisms of IL-10 gene with susceptibility to lung cancer: systematic review and meta-analysis. Asian Pac J Cancer Prev. 2019;20:1951–7. doi:https://doi.org/10.31557/APJCP.2019.20.7.1951.